AUGUST 2026
The Consumer Healthcare market is at a genuine turning point. The need for the New Paradigms Executive Platform has never been greater.
Consumer Healthcare has entered a fundamentally different market environment.
The strategic questions leadership teams need to answer have changed.
Following the post-pandemic surge, growth has slowed and competition has intensified. Macro and micro-economic pressures are forcing difficult trade-offs, leaving many organisations focused on short-term performance at the expense of long-term growth. In a largely static volume market, growth increasingly comes from winning share from competitors. At the same time, all major organisations across the industry have restructured, changed ownership and/or focused on improving profitability.
The next strategic decision is no longer how to reduce costs. It is when to take your foot off the brake and when to accelerate your next growth bets.
The next phase of growth will be driven by a different set of circumstances. The GLP-1 revolution is creating entirely new markets, while Rx-to-OTC Switch, Emerging Markets and even long-established categories such as Cough & Cold require a fundamental strategic rethink. AI, changing consumer behaviour and evolving retail ecosystems are rewriting the rules of competition.
That is why Nicholas Hall has been inspired to write New Paradigms 2027.
His aim is not simply to describe change, but to challenge assumptions, provoke debate and show where the next sources of competitive advantage will come from, so that industry leaders and executives can make bolder strategic choices.
New Paradigms 2027 is more than a report, it has evolved into an Executive Platform. The foundation report will be complemented by Quarterly Strategic Briefings throughout 2026-27, so that leadership teams will always have a current view of key developments and be able to reassess priorities and act before their competitors.
New Paradigms 2027 has been scoped and the prospectus is available now!
Get in touch with us directly if you have any questions or comments, e: marta.babits@NicholasHall.com